This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alkermes PLC (ALKS)

NASDAQ: Health Care

Company Cash Flow
Dec 2014 Dec 2013 Mar 2013 Mar 2012
Cash Flow From Operating Activities
Net Income (Loss) -30.06M 0.00 24.98M -113.68M
Operating Gains/Losses -55.40M 0.00 19.67M 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -17.40M 0.00 -28.24M -14.01M
(Increase) Decrease in Inventories -31.24M 0.00 -6.58M -4.88M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 56.90M 0.00 19.41M 11.22M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 2.60M 0.00 -33.00K 6.58M
Other Non-Cash Items 6.84M 0.00 25.70M 33.17M
Net Cash From Continuing Operations 11.14M 0.00 126.55M -2.48M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 11.14M 0.00 126.55M -2.48M
Sale of Property, Plant & Equipment 44.37M 0.00 193.00K 35.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -33.65M 0.00 -22.22M -16.99M
Acquisitions 0.00 0.00 0.00 -494.77M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 27.19M 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -263.40M 0.00 -68.15M -417.16M
Issuance of Debt 0.00 0.00 366.48M 444.10M
Cash Used for Financing Activities
Issuance of Capital Stock 47.58M 0.00 34.36M 17.19M
Repayment of Long-Term Debt -6.75M 0.00 -449.94M -775.00K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 267.93M 0.00 4.06M 4.33M
Net Cash From Financing Activities 308.76M 0.00 -45.04M 464.85M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 56.50M 0.00 13.36M 45.21M

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for ALKS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 0 0 0 0
Hold 1 1 2 3
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1

ALKS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs